LAB Logo

Standard BioTools Inc. (LAB) 

NASDAQ
Market Cap
$744.52M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
33 of 960
Rank in Industry
1 of 52

Largest Insider Buys in Sector

LAB Stock Price History Chart

LAB Stock Performance

About Standard BioTools Inc.

Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical …

Insider Activity of Standard BioTools Inc.

Over the last 12 months, insiders at Standard BioTools Inc. have bought $18.49M and sold $0 worth of Standard BioTools Inc. stock.

On average, over the past 5 years, insiders at Standard BioTools Inc. have bought $8.89M and sold $514,009 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Casdin Partners Master Fund, L.P. () — $110.93M.

The last purchase of 250,000 shares for transaction amount of $546,750 was made by Casdin Partners Master Fund, L.P. () on 2024‑08‑27.

List of Insider Buy and Sell Transactions, Standard BioTools Inc.

2024-08-27Purchase
250,000
0.0798%
$2.19$546,750-12.84%
2024-08-26Purchase
150,000
0.0471%
$2.15$322,455-12.44%
2024-08-23Purchase
292,100
0.0907%
$2.13$620,975-11.21%
2024-08-22Purchase
307,900
0.088%
$1.96$602,807-2.31%
2024-08-21Purchase
500,000
0.139%
$1.90$951,950-1.55%
2024-08-20Purchase
500,000
0.1368%
$1.87$936,700+2.96%
2024-08-19Purchase
250,000
0.0676%
$1.85$463,2250.00%
2024-08-14Purchase
1.2M
0.2794%
$1.59$1.91M+22.90%
2024-08-13Purchase
550,000
0.13%
$1.62$890,560+16.56%
2024-08-12Purchase
500,000
0.1198%
$1.64$820,600+19.50%
2024-08-09Purchase
525,408
0.1239%
$1.61$848,481+17.28%
2024-08-08Purchase
569,562
0.1362%
$1.64$932,601+13.47%
2024-08-07Purchase
500,000
0.1148%
$1.57$786,200+19.62%
2024-08-05Purchase
200,000
0.0462%
$1.58$316,780+18.87%
2024-08-02Purchase
1M
0.2382%
$1.63$1.63M+14.55%
2024-05-23Purchase
100,000
0.038%
$2.60$260,000-26.05%
2024-05-22Purchase
150,000
0.0566%
$2.58$387,735-25.48%
2024-05-21Purchase
350,000
0.1308%
$2.56$895,930-25.19%
2024-05-20Purchase
100,000
0.0377%
$2.58$258,130-25.19%
2024-05-17Purchase
352,072
0.1317%
$2.56$902,044-24.90%

Insider Historical Profitability

16.03%
Casdin Partners Master Fund, L.P.
54025821
14.513%
$2.00270+12.56%
Caligan Partners LP10 percent owner
11444836
3.0744%
$2.00180<0.0001%
JOHNSON DAVID EDWARD
11189663
3.0059%
$2.0080<0.0001%
LEVIN CAPITAL STRATEGIES, L.P.10 percent owner
10473809
2.8136%
$2.001110+23.89%
TORRAY ROBERT Edirector
2381164
0.6397%
$2.0040

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.